HUMAN ALVEOLAR MACROPHAGE ELASTASES IN EMPHYSEMA

肺气肿中的人肺泡巨噬细胞弹性蛋白酶

基本信息

  • 批准号:
    2224331
  • 负责人:
  • 金额:
    $ 25.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1993
  • 资助国家:
    美国
  • 起止时间:
    1993-01-01 至 1997-12-31
  • 项目状态:
    已结题

项目摘要

Macrophages are prominent in the histopathology of emphysema and other chronic inflammatory processes characterized by excessive connective tissue turnover. The overall objective of this proposal is to define the role of lung macrophages in the pathobiology of smoking-related chronic lung disease. Recent cloning of all four of the known eukaryotic cysteine proteases has identified one of these, human cathepsin S, as an elastase. Cathepsin S has been found to have appreciable elastase activity at both acidic and neutral pH. Evidence indicates that alveolar macrophages from smokers have increased activity over those of nonsmoker cells of cathepsin S. This macrophage elastase activity is inducible in vitro by co-culture of live cells with elastin and potentially regulated by two endogenous inhibitors secreted by these same cells, TIMP and cystatin C. Experiments are directed toward the central hypothesis that dysregulation of macrophage elastase activity -- inducible by cigarette smoking -- is an important determinant of lung injury. In order to test this hypothesis antibodies to recombinant human cathepsin S will be raised to assist in further purification and characterization of the enzyme. The mechanism of increased cathepsin S activity in smoker macrophages will be examined and whether cysteine proteases exist on the macrophage cell surface defined by immunologic and electron microscopic techniques. the influence of extracellular matrix proteins, elastin receptors, and cytokines on the expression of macrophage cathepsins S and L, as well a the 92-kDa gelatinase, will be studied by mRNA and functional assays in vitro. The functional importance of cystatin C and TIMP in regulating matrix metabolism by macrophages will be assessed, in part, by partially blocking cystatin C and TIMP biosynthesis with antisense oligonucleotides and measuring the effects on extracellular matrix degradation by macrophages. Finally, macrophage expression of cathepsins S and L, the 92-kDa gelatinase, and the inhibitors TIMP and cystatin C will be examined in alveolar macrophages obtained from cigarette smokers with normal or reduced lung function (FEV1/FVC). These experiments should elucidate the molecular process by which human macrophages degrade elastin, define its regulation in vitro, and directly test whether altered enzyme and/or inhibitor expression by macrophages is implicated in the pathobiology of smoking-related lung disease. The results should provide a clearer view of the role of macrophages in emphysema and a sound foundation for future efforts both to monitor and to modulate macrophage proteolysis in vivo.
在肺气肿和其他疾病的组织病理学中, 以过度结缔组织为特征的慢性炎症过程 组织周转 本提案的总体目标是界定 肺巨噬细胞在吸烟相关慢性肺损伤病理生物学中的作用 肺病。 最近克隆了所有四种已知的真核生物 半胱氨酸蛋白酶已经鉴定了其中之一,人组织蛋白酶S,作为一种蛋白酶。 弹性蛋白酶 已发现组织蛋白酶S具有可观的弹性蛋白酶 活性在酸性和中性pH值。证据表明,肺泡 吸烟者的巨噬细胞比非吸烟者的活性高 组织蛋白酶S细胞。 这种巨噬细胞弹性蛋白酶活性是可诱导的, 通过活细胞与弹性蛋白的共培养进行体外研究, 由这些相同的细胞分泌的两种内源性抑制剂,TIMP和 半胱氨酸蛋白酶抑制剂C。 实验是针对中心假设, 香烟诱导的巨噬细胞弹性蛋白酶活性失调 吸烟是肺损伤的重要决定因素。 为了测试 这一假设将重组人组织蛋白酶S的抗体 以帮助进一步纯化和表征 酵素 吸烟者组织蛋白酶S活性升高的机制 将检查巨噬细胞,以及半胱氨酸蛋白酶是否存在于巨噬细胞上。 免疫学和电子显微镜确定的巨噬细胞表面 技术. 细胞外基质蛋白、弹性蛋白 受体和细胞因子对巨噬细胞组织蛋白酶S和 L,以及92-kDa明胶酶,将通过mRNA和 体外功能测定。 半胱氨酸蛋白酶抑制剂C的功能重要性, 将评估TIMP在调节巨噬细胞基质代谢中的作用, 部分,通过部分阻断半胱氨酸蛋白酶抑制剂C和TIMP的生物合成, 反义寡核苷酸和测量对细胞外 巨噬细胞的基质降解。 最后,巨噬细胞表达 组织蛋白酶S和L,92-kDa明胶酶,以及抑制剂TIMP和 半胱氨酸蛋白酶抑制剂C将在肺泡巨噬细胞中进行检查, 吸烟者肺功能正常或降低(FEV 1/FVC)。 这些 这些实验应该阐明人类 巨噬细胞降解弹性蛋白,在体外定义其调节,并直接 测试巨噬细胞是否改变酶和/或抑制剂表达 与吸烟相关的肺部疾病的病理学有关。 的 结果应该提供一个更清楚的观点,巨噬细胞的作用, 肺气肿和良好的基础,为今后的努力, 以调节体内巨噬细胞蛋白水解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Harold A Chapman其他文献

Harold A Chapman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Harold A Chapman', 18)}}的其他基金

Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients
IPF 患者口服表没食子儿茶素-3-没食子酸酯 (EGCG) 的 1 期研究
  • 批准号:
    10702133
  • 财政年份:
    2022
  • 资助金额:
    $ 25.75万
  • 项目类别:
Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients
IPF 患者口服表没食子儿茶素-3-没食子酸酯 (EGCG) 的 1 期研究
  • 批准号:
    10418169
  • 财政年份:
    2022
  • 资助金额:
    $ 25.75万
  • 项目类别:
Program to promote lung regeneration and block fibrosis
促进肺再生和阻止纤维化的计划
  • 批准号:
    9893639
  • 财政年份:
    2020
  • 资助金额:
    $ 25.75万
  • 项目类别:
Program to promote lung regeneration and block fibrosis
促进肺再生和阻止纤维化的计划
  • 批准号:
    10570862
  • 财政年份:
    2020
  • 资助金额:
    $ 25.75万
  • 项目类别:
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage
上皮干/祖细胞作为弥漫性肺泡损伤的修复剂
  • 批准号:
    10181019
  • 财政年份:
    2016
  • 资助金额:
    $ 25.75万
  • 项目类别:
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage
上皮干/祖细胞作为弥漫性肺泡损伤的修复剂
  • 批准号:
    10418711
  • 财政年份:
    2016
  • 资助金额:
    $ 25.75万
  • 项目类别:
Epithelial stem/progenitor cells as repair agents in diffuse alveolar damage
上皮干/祖细胞作为弥漫性肺泡损伤的修复剂
  • 批准号:
    9355470
  • 财政年份:
    2016
  • 资助金额:
    $ 25.75万
  • 项目类别:
Epithelial Stem/Progenitor Cells in Repair of the Injured Lung
上皮干细胞/祖细胞修复受损肺
  • 批准号:
    9109038
  • 财政年份:
    2015
  • 资助金额:
    $ 25.75万
  • 项目类别:
Identification, Isolation, and Reprogramming Alveolar Epithelial Progenitor Cells
肺泡上皮祖细胞的鉴定、分离和重编程
  • 批准号:
    7676645
  • 财政年份:
    2008
  • 资助金额:
    $ 25.75万
  • 项目类别:
Urokinase Receptor Integrin Interactions in Lung Cancer
肺癌中尿激酶受体整合素相互作用
  • 批准号:
    7318124
  • 财政年份:
    2007
  • 资助金额:
    $ 25.75万
  • 项目类别:

相似海外基金

Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
  • 批准号:
    22K09003
  • 财政年份:
    2022
  • 资助金额:
    $ 25.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
  • 批准号:
    21K07762
  • 财政年份:
    2021
  • 资助金额:
    $ 25.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
  • 批准号:
    20K16927
  • 财政年份:
    2020
  • 资助金额:
    $ 25.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
  • 批准号:
    20H00526
  • 财政年份:
    2020
  • 资助金额:
    $ 25.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
  • 批准号:
    20K21245
  • 财政年份:
    2020
  • 资助金额:
    $ 25.75万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
  • 批准号:
    G0900887/1
  • 财政年份:
    2011
  • 资助金额:
    $ 25.75万
  • 项目类别:
    Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
  • 批准号:
    05558090
  • 财政年份:
    1993
  • 资助金额:
    $ 25.75万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
  • 批准号:
    04453031
  • 财政年份:
    1992
  • 资助金额:
    $ 25.75万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了